<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="ongoing to further evaluate efficacy in affected patients. Although ritonavir-boosted" exact="lopinavir" post="showed some antiviral effect on SARS-CoV-2 in vitro, a"/>
 <result pre="compared to no treatment.28 Other drugs currently under evaluation include" exact="chloroquine" post="phosphate or hydroxychloroquine.29 Chloroquine has shown antiviral efficacy against"/>
 <result pre="with certain immunosuppressive therapies where drug levels of cyclosporine, tacrolimus," exact="sirolimus" post="or everolimus will have to be closely monitored. In"/>
 <result pre="immunosuppressive therapies where drug levels of cyclosporine, tacrolimus, sirolimus or" exact="everolimus" post="will have to be closely monitored. In addition, patients"/>
 <result pre="hepatitis B and C •Liver toxicity (↑ALT) possible Chloroquine/Hydroxychloroquine35 ±" exact="azithromycin" post="•Interference with the cellular receptor ACE224 •Endosomal acidification fusion"/>
 <result pre="AST possible. •No data in cirrhosis available Sofosbuvir∗maybe combination with" exact="ribavirin" post="•Nucleotide analogue, RdRp-inhibitor •Approved for treatment of chronic hepatitis"/>
 <result pre="(see Table 1 for guidance with regards to CLD) •Prevent" exact="acetaminophen" post="overdosing (2–3 g/day is considered safe in patients with"/>
 <result pre="molecule GS-5734 against Ebola virus in rhesus monkeysNature531201638138526934220 24WangM.CaoR.ZhangL.YangX.LiuJ.XuM.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="in adults hospitalized with severe Covid-19N Engl J Med2020 29GaoJ.TianZ.YangX.Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="to treat coronavirus disease 2019 (COVID-19)Drug Discoveries Ther1420205860 32GautretP.LagierJ.-C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="challengeMayo Clinic Proc852010451458 34COVID-19 Drug interactions2020Available from:http://www.covid19-druginteractions.org/ 35[Expert consensus on" exact="chloroquine" post="phosphate for the treatment of novel coronavirus pneumonia]Zhonghua Jie"/>
 <result pre="He He Hu Xi Za Z432020E019 36Al-BariM.A.A.Targeting endosomal acidification by" exact="chloroquine" post="analogs as a promising strategy for the treatment of"/>
 <result pre="in SingaporeJAMA2020[Epub ahead of print] 38CasadoJ.L.Del PalacioM.MoyaJ.RodriguezJ.M.MorenoA.Perez-ElíasM.J.Safety and pharmacokinetics of" exact="lopinavir" post="in HIV/HCV coinfected patients with advanced liver diseaseHIV Clin"/>
 <result pre="diseaseHIV Clin Trials12201123524322180521 39GenoveseM.C.KremerJ.M.van VollenhovenR.F.AltenR.ScaliJ.J.KelmanA.Transaminase levels and hepatic events during" exact="tocilizumab" post="treatment: pooled analysis of long-term clinical trial safety data"/>
 <result pre="long-term clinical trial safety data in rheumatoid arthritisArthritis Rheumatol6920171751176128597609 40ChenL.-F.MoY.-Q.JingJ.MaJ.-D.ZhengD.-H.DaiL.Short-course" exact="tocilizumab" post="increases risk of hepatitis B virus reactivation in patients"/>
 <result pre="pancreatitis (TACTIC)Trials20201950131412955 50Press release on planned clinical trials to evaluate" exact="anakinra" post="and emapalumab in COVID-19. 2020. Available from: https://www.sobi.com/en/press-releases/sobi-initiate-clinical-study-evaluate-whether-anakinra-and-emapalumab-may-relieve. [Accessed"/>
</results>
